Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Trigilio Jeffrey
Chief Financial Officer at Cullinan Therapeutics. Filing since 12 Jan 2021.
CIK 0001838671
Company
Date
Role
Action
Shares
Amount
Of holding
CGEM
Cullinan Therapeutics, Inc.
21 Dec 2023
Chief Financial Officer
Sold at will
1,920
$16.32K
2.2%
CGEM
Cullinan Therapeutics, Inc.
18 Dec 2023
Chief Financial Officer
Sold at will
398
$3.27K
0.5%
CGEM
Cullinan Therapeutics, Inc.
12 Dec 2023
Chief Financial Officer
Sold at will
1,926
$15.04K
2.2%
CGEM
Cullinan Therapeutics, Inc.
20 Jun 2023
Chief Financial Officer
Sold at will
399
$5.16K
0.5%
CGEM
Cullinan Therapeutics, Inc.
12 Jun 2023
Chief Financial Officer
Sold at will
319
$4.18K
0.4%
CGEM
Cullinan Therapeutics, Inc.
18 May 2023
Chief Financial Officer
Sold at will
399
$3.50K
0.5%
CGEM
Cullinan Therapeutics, Inc.
12 May 2023
Chief Financial Officer
Sold at will
347
$3.05K
0.4%
CGEM
Cullinan Therapeutics, Inc.
18 Apr 2023
Chief Financial Officer
Sold at will
398
$4.26K
0.5%
CGEM
Cullinan Therapeutics, Inc.
12 Apr 2023
Chief Financial Officer
Sold at will
318
$3.25K
0.4%
CGEM
Cullinan Therapeutics, Inc.
20 Mar 2023
Chief Financial Officer
Sold at will
399
$4.52K
0.5%
CGEM
Cullinan Therapeutics, Inc.
15 Oct 2021
Chief Financial Officer
Sold, plan not stated
8,000
$200.00K
78.0%
CGEM
Cullinan Therapeutics, Inc.
8 Sep 2021
Chief Financial Officer
Sold, plan not stated
15,000
$427.15K
87.0%
CGEM
Cullinan Therapeutics, Inc.
12 Jan 2021
Chief Financial Officer
Bought
2,250
$47.25K
opened
13 decisions on file.
